Standard Dental Labs Inc. (OTCMKTS: TUTH) is pleased to announce the appointment of Nirmal Sekhri to its Board of Directors, effective immediately.
Mr. Sekhri is a seasoned entrepreneur and strategic sales executive with over two decades of experience negotiating complex transactions, leading high-performing teams, and building strong commercial partnerships. As a key player at Trane Technologies, Mr. Sekhri oversaw more than $187 million in contracted sales with marquee clients, including Walgreens, McDonald’s, and Siemens. He also founded TheraSpa Service Group, scaling it into Arizona’s largest spa and water care provider.
“Nirmal brings a wealth of commercial and strategic experience to our board at a time when Standard Dental Labs is accelerating its growth and expanding its footprint across Florida,” said James Brooks, CEO of Standard Dental Labs. “His proven track record in both corporate and entrepreneurial ventures will be invaluable as we continue to execute our acquisition-driven business model.”
Mr. Sekhri’s appointment comes as Standard Dental Labs continues its mission to consolidate and modernize the dental laboratory industry through strategic acquisitions and operational excellence.
About Standard Dental Labs Inc.
Standard Dental Labs Inc. (OTCMKTS: TUTH) is a growth-focused dental laboratory group dedicated to delivering high-quality dental prosthetics and restorations. The company is actively expanding its presence through acquisitions of private dental labs across Florida, aiming to raise industry standards and enhance service delivery through innovation and scale.
Website: https://sdl.care/investors.
Forward-Looking Statements
This press release and the statements of representatives of SDL related thereto contain, or may contain, among other things, “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact included herein, are “forward-looking statements,” including any other statements of non-historical information. These forward-looking statements are subject to significant known and unknown risks and uncertainties and are often identified by the use of forward-looking terminology such as “guidance,” “projects,” “may,” “could,” “would,” “should,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “ultimately,” or similar expressions. All forward-looking statements involve material assumptions, risks, and uncertainties, and the expectations contained in such statements may prove to be incorrect.
Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company’s actual results (including, without limitation, SDL’s ability to advance its business, generate revenue and profit, and operate as a public company) could differ materially from those stated or anticipated in these forward-looking statements as a result of various factors, including risks discussed in the periodic reports that the company files with OTC Markets (Pink Sheets). All forward-looking statements attributable to the company or persons acting on its behalf are expressly qualified in their entirety by these factors. The company undertakes no duty to update these forward-looking statements except as required by law.
